-
2 months ago | 
dx.doi.org | Xingyu Chen |Jingchun Feng |Yan Xie |Longhang Xu
-
Oct 25, 2024 | 
mdpi.com | Yan Xie |Maree Davies |Joanna Smith
1. IntroductionPolicy implementation has been a key focus in public policy since Pressman and Wildavsky’s publication in 1973, which highlighted the complexity of the implementation process and the importance of understanding the local context for effective outcomes [1]. Ball recognised that the notion of policy being “implemented” carries an idealised view, which assumes that policy is executed by rational policy agents with abundant resources in the best possible contexts [2].
-
May 20, 2024 | 
arxiv.org | Yan Xie
arXiv:2405.11730 (cs) View PDF HTML (experimental) Comments: Subjects: Machine Learning (cs.LG); General Finance (q-fin.GN) Cite as: arXiv:2405.11730 [cs.LG] (or arXiv:2405.11730v1 [cs.LG] for this version) Submission history From: Jiahao Weng [ view email] [v1] Mon, 20 May 2024 02:24:36 UTC (1,291 KB) Bibliographic Tools Bibliographic Explorer Toggle Bibliographic Explorer () Litmaps Toggle Litmaps (What is Litmaps?) scite.ai Toggle scite Smart Citations (What are Smart Citations?) Code,...
-
May 15, 2024 | 
jamanetwork.com | Yan Xie |Taeyoung Choi |Ziyad Al-Aly
In the first year of the COVID-19 pandemic, risk of death in people hospitalized for COVID-19 was substantially higher than in people hospitalized for seasonal influenza.1,2 The risk of death due to COVID-19 has since declined.
-
May 15, 2024 | 
jamanetwork.com | Rebecca Bystrom |Daniel DeAngelo |Jacqueline Garcia |Yan Xie
Yan Xie, PhD; Taeyoung Choi, MS; Ziyad Al-Aly, MD JAMA. Published online May 15, 2024. doi:10.1001/jama.2024.7395 This cohort study evaluates the risk of death in patients hospitalized for COVID-19 or seasonal influenza following the emergence of the JN.1 variant in winter 2023. Gregory Curfman, MD JAMA. Published online May 15, 2024.
-
Apr 25, 2024 | 
dx.doi.org | Zhenwu Zhou |Jingchun Feng |Yan Xie |Bin Wang
Download Hi-Res ImageDownload to MS-PowerPointCite This:Energy Fuels 2024, XXXX, XXX This article has not yet been cited by other publications.
-
Jan 31, 2024 | 
jamanetwork.com | Rita Rubin |Melissa Suran |Yan Xie |Taeyoung Choi
Anyone who watches television has probably seen the Pfizer commercial with the tagline, “If it’s COVID, Paxlovid.” That might be a catchy slogan, but, apparently, a lot of people aren’t getting the message. The US Food and Drug Administration (FDA) approved Paxlovid last May for the treatment of mild to moderate COVID-19 in adults who are at risk of progression to severe disease.
-
Dec 14, 2023 | 00684-9/fulltext&sz=64)
thelancet.com | Yan Xie |Taeyoung Choi |Ziyad Al-Aly
Research in contextEvidence before this studyWe searched PubMed for studies published between Dec 12, 2019, and Sept 10, 2023, using the search terms “COVID-19” and “SARS-CoV-2” in combination with the search terms “seasonal influenza”, “flu”, OR “influenza”, with no language restrictions.
-
Nov 21, 2023 | 00292-9/abstract&sz=64)
thelancet.com | Yan Xie |Ziyad Al-Aly
We thank Ali Ahmed and colleagues for their interest in our study of the comparative effectiveness of four antihyperglycaemics on the risk of major adverse cardiovascular events (MACE). 1Xie Y Bowe B Xian H Loux T McGill JB Al-Aly Z Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records.
-
Aug 21, 2023 | 
nature.com | Yan Xie |Ziyad Al-Aly
AbstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to postacute sequelae in multiple organ systems, but evidence is mostly limited to the first year postinfection.
